AEON Biopharma, Inc. (AEON) announced Wednesday a workforce reduction by approximately 55% as part of its strategic reprioritization and cost reduction plan. The company has terminated Peter Reynolds as the chief financial officer, principal financial officer and principal accounting officer, effective as of May 17, under its cash preservation strategy.